全文获取类型
收费全文 | 648篇 |
免费 | 40篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 40篇 |
妇产科学 | 3篇 |
基础医学 | 54篇 |
口腔科学 | 13篇 |
临床医学 | 100篇 |
内科学 | 130篇 |
皮肤病学 | 8篇 |
神经病学 | 51篇 |
特种医学 | 138篇 |
外科学 | 29篇 |
综合类 | 18篇 |
预防医学 | 30篇 |
眼科学 | 6篇 |
药学 | 64篇 |
中国医学 | 1篇 |
肿瘤学 | 46篇 |
出版年
2023年 | 4篇 |
2022年 | 7篇 |
2021年 | 3篇 |
2020年 | 3篇 |
2019年 | 2篇 |
2018年 | 7篇 |
2017年 | 5篇 |
2016年 | 2篇 |
2015年 | 8篇 |
2014年 | 15篇 |
2013年 | 18篇 |
2012年 | 11篇 |
2011年 | 14篇 |
2010年 | 26篇 |
2009年 | 33篇 |
2008年 | 15篇 |
2007年 | 42篇 |
2006年 | 12篇 |
2005年 | 13篇 |
2004年 | 7篇 |
2003年 | 14篇 |
2002年 | 12篇 |
2001年 | 11篇 |
2000年 | 14篇 |
1999年 | 13篇 |
1998年 | 42篇 |
1997年 | 34篇 |
1996年 | 38篇 |
1995年 | 26篇 |
1994年 | 17篇 |
1993年 | 21篇 |
1992年 | 14篇 |
1991年 | 9篇 |
1990年 | 16篇 |
1989年 | 32篇 |
1988年 | 34篇 |
1987年 | 26篇 |
1986年 | 19篇 |
1985年 | 15篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1982年 | 9篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1979年 | 2篇 |
1978年 | 6篇 |
1977年 | 11篇 |
1976年 | 5篇 |
1975年 | 5篇 |
1967年 | 2篇 |
排序方式: 共有734条查询结果,搜索用时 15 毫秒
731.
732.
733.
Jared W. Castle Danielle M. Butzbach G. Stewart Walker Claire E. Lenehan Frank Reith Samuel P. Costello K. Paul Kirkbride 《Drug testing and analysis》2023,15(5):551-565
Recent research reported that lurasidone degrades in unpreserved ante-mortem human whole blood inoculated with microorganisms known to dominate postmortem blood specimens. In vitro degradation occurred at a similar rate to risperidone, known to degrade in authentic postmortem specimens until below analytical detection limits. To identify the lurasidone degradation products formed, an Agilent 6520 liquid chromatograph quadrupole-time-of-flight mass spectrometer (LC-QTOF-MS) operating in auto-MS/MS mode was used. Numerous degradation products not previously reported in prior in vitro or in vivo pharmacokinetic studies or forced degradation studies were detected. Accurate mass data, mass fragmentation data, acetylation experiments, and a proposed mechanism of degradation analogous to risperidone supports initial identification of the major degradation product as N-debenzisothiazole-lurasidone (calculated m/z [M + H]+ = 360.2646). A standard was unavailable to conclusively confirm this identification. Retrospective data analysis of postmortem cases involving lurasidone identified the presence of the major degradation product in four of six cases where lurasidone was also detected. This finding is significant for toxicology laboratories screening for this drug in postmortem casework. The major postmortem lurasidone degradation product has consequently been added to the LC-QTOF-MS drug screen at Forensic Science SA (FSSA) to indicate postmortem lurasidone degradation in authentic postmortem blood specimens and as a marker of lurasidone administration in the event lurasidone is degraded to concentrations below detection limits. 相似文献
734.
Jared W. Castle Danielle M. Butzbach G. Stewart Walker Claire E. Lenehan Frank Reith Samuel P. Costello K. Paul Kirkbride 《Drug testing and analysis》2023,15(2):220-234
A systematic study was performed into the degradation of ziprasidone in simulated postmortem blood. Fifteen potential degradation products not previously reported in the literature were observed. Four resulted from degradation in human blood, whereas the remaining products resulted from reaction with solvents: four from alkaline degradation, four from reaction with acetaldehyde, and three from reaction with acetone. To identify possible degradation products, a liquid chromatograph-diode array detector (LC-DAD) and liquid chromatograph quadrupole-time-of-flight mass spectrometer (LC-QTOF-MS) operating in auto-MS/MS mode were used. It was indicated from red-shifted UV–Vis spectra, accurate mass data, mass fragmentation data, and a deuteration experiment that the site of ziprasidone degradation, in the in vitro blood experiments, was the methylene carbon of the oxindole moiety. The major in vitro blood degradation products were proposed to be E/Z isomers of 3-ethylidene-ziprasidone. Further, another in vitro degradation product in microbially inoculated blood specimens was proposed to be 3-ethyl-ziprasidone. 3-Ethylidene-ziprasidone was hypothesized to form from the reaction of ziprasidone with acetaldehyde derived from the ethanol used to spike ziprasidone into the in vitro blood experiments. Data from two postmortem investigations were available for retrospective reanalysis. Attempts were made to detect degradation products of ziprasidone, but none were found. 相似文献